Utilization and outcomes of the 21-gene recurrence score in de novo metastatic breast cancer-Reference-Cited by-同舟云学术

Utilization and outcomes of the 21-gene recurrence score in de novo metastatic breast cancer

Published:2024-01-05 Issue:1-2 Volume:24 Page:99-106
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Yang Shi-Ping¹,Liu Ke²,Li Yang³,Li Guan-Qiao⁴,Li Jia-Yi⁵,Lin Yu-Yi⁶,Wu San-Gang⁷^ORCID

Affiliation:

1. Department of Radiation Oncology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, People’s Republic of China

2. Department of Traditional Chinese Medicine, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People’s Republic of China

3. School of Basic Medical Sciences, Fujian Medical University, Fuzhou, People’s Republic of China

4. Department of Breast Surgery, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, People’s Republic of China

5. Department of Medical Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People’s Republic of China

6. Department of Radiation Oncology, the Second Affiliated Hospital of Xiamen Medical College, Xiamen, People’s Republic of China

7. Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People’s Republic of China

Funder

Social Development Projects of Key R & D Programs in Hainan Province

the Project of the Xiamen Municipal Health Commission

the Hainan Province Health Industry Scientific Research Project

Commission Young and Middle-aged Talents Training Project of Fujian Health Commission

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2024.2301940

Reference35 articles.

1. Stage-Specific Survival in Breast Cancer in Chinese and White Women: Comparative Data Analysis

2. Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database

3. Predictive value of breast cancer molecular subtypes in Chinese patients with four or more positive nodes after postmastectomy radiotherapy

4. Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer

5. The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions